EDGAR Filing Documents for 0001193125-06-203102

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

SEC Accession No. 0001193125-06-203102

Filing Date

2006-10-05

Accepted

2006-10-05 09:06:27

Documents

Group Members

ATLAS GLOBAL INVESTMENTS II, LTDATLAS GLOBAL INVESTMENTS, LTD.ATLAS GLOBAL, LLCATLAS MASTER FUND, LTD.DMITRY BALYASNYVISIUM BALANCED FUND, LPVISIUM BALANCED LONG BIAS FUND, LTD.VISIUM BALANCED OFFSHORE FUND, LTDVISIUM CAPITAL MANAGEMENT, LLCVISIUM LONG BI

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13G AMENDMENT NO. 1	dsc13ga.htm	SC 13G/A	286627
	Complete submission text file	0001193125-06-203102.txt		288772

Mailing Address

Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300

ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-81801 | Film No.: 061129890
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602

Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999

BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A